Famotidine Injection, Solution
Product Images NDC 51662-1375

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 51662-1375). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ped 3 (Clinc P In P 3)

A data table presenting dosage, route, effect on gastric pH, and number of patients for famotidine administration. Dosages range from 0.3 mg/kg single dose to 0.5 mg/kg b.i.d., administered intravenously or orally. Effects report gastric pH values and duration, with patient counts from 4 to 18 in each group.*

FDA Label Image

Adults 1 (Clinic P In A 1)

A data table comparing efficacy results among three groups: Famotidine 40 mg h.s. (N=89), Famotidine 20 mg b.i.d. (N=84), and Placebo (N=97). Results are shown for Week 2 and Week 4, with percentages of response indicated for each group.*

FDA Label Image

Adults 2 (Clinic P In A 2)

A data table comparing the percentage outcomes of Famotidine 40 mg taken at bedtime versus placebo in U.S. and international studies, showing results at weeks 4, 6, and 8. The U.S. study includes 74 and 75 participants in the Famotidine and placebo groups respectively, while the international study includes 149 and 145 participants. The table highlights the increased percentages of effectiveness for Famotidine over placebo across all time points in both studies.*

FDA Label Image

Adult 4 (Clinic P In A 4)

A data table comparing the results of Famotidine 40 mg b.i.d., Famotidine 20 mg b.i.d., and placebo treatments. It shows sample sizes (N=127, 125, and 66) and results at Week 6 and Week 12, with numerical values reported for each group.*

FDA Label Image

Adult 5 (Clinic P In A 5)

A data table comparing clinical study results for Famotidine 40 mg b.i.d., Famotidine 20 mg b.i.d., and Ranitidine 150 mg b.i.d. It shows the number of subjects (N=175, 93, and 172 respectively) and outcome values at Week 6 and Week 12.*

FDA Label Image

Ped 1 (Clinic P In P 1)

A data table presenting pharmacokinetic parameters of Famotidine injection, solution in different age groups. It includes age categories with patient numbers, area under the curve (AUC) in ng·hr/mL, total clearance (Cl) in L/hr/kg, volume of distribution (Vd) in L/kg, and elimination half-life (T1/2) in hours, with values shown for 1-11 years, 11-15 years, and adults.*

FDA Label Image

Ped 2 (Clinic P In P 2)

A data table showing EC 50 (ng/mL) values for famotidine in different groups: pediatric patients with a value of 26 ± 13, healthy adult subjects with 26.5 ± 10.3, and adult patients with upper GI bleeding with 18.7 ± 10.8. The table notes data are from one study.*

FDA Label Image

How Supplied (How Supplied)

A data table presenting product packaging information including product code, unit of sale, strength, and individual package details. It lists a product with NDC 63323-739-12 sold in units of 25, strength 20 mg per 2 mL (10 mg per mL), and single 2 mL dose vials identified by NDC 63323-739-11.*

FDA Label Image

Logo (Logo)

FAMOTIDINE 10 mg/mL intravenous injection solution vial by HF Acquisition Co LLC, DBA HealthFirst. The clear glass vial has a white and blue cap and a label with the product name, strength, and manufacturer information. The vial holds an unspecified volume of solution.*

FDA Label Image

Serialized Labeling (Serialized Labeling)

FAMOTIDINE injection, USP vial with strength 20 mg/2 mL (10 mg/mL). Clear glass vial with peach-colored flip cap. Label shows product name, concentration, volume, and indicates for intravenous use only. Manufacturer or distributor noted is HF Acquisition Co LLC, DBA HealthFirst. Included barcode and lot information visible.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of famotidine, showing its molecular formula C8H15N7O2S3 and molecular weight of 337.45.*

FDA Label Image

Vial Label (Vial Label)

FAMOTIDINE Injection, USP 20 mg/2 mL single dose vial label for intravenous use only after dilution. The label states each 1 mL contains 10 mg famotidine and inactive ingredients, with storage instructions between 2° to 8°C. Manufactured by APP Pharmaceuticals, LLC.*

FDA Label Image

Adults 3 (Clinic P In A 3)

A table presenting numerical data for three groups: Famotidine 20 mg twice daily, Famotidine 40 mg at bedtime, and placebo, with sample sizes listed and data values for week 6.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.